![APTO stock - APTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600-768x432.png)
Source: iQoncept / Shutterstock
Aptose Biosciences (NASDAQ:APTO) recently unveiled its performance for the initial quarter of 2024.
- Aptose Biosciences surpassed expectations by reporting earnings per share of -73 cents, slightly better than the projected -74 cents.
- Despite this positive development, the company did not disclose any revenue figures for the period.
Article printed from InvestorPlace Media
© 2024 InvestorPlace Media, LLC